Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infliximab in a child with therapy-resistant systemic vasculitis.

Literature DB >> 16267606

Infliximab in a child with therapy-resistant systemic vasculitis.

Sandra W K de Kort¹, Marion A J van Rossum, Rebecca ten Cate.

Abstract

Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with systemic vasculitis resistant to immunosuppressive treatment who had a rapid and impressive response to treatment with infliximab.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2005 PMID： 16267606 DOI： 10.1007/s10067-005-0071-7

Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980

14 in total

Review 1. The spectrum of vasculitis in children.

Authors: S Ozen
Journal: Best Pract Res Clin Rheumatol Date: 2002-07 Impact factor: 4.098

2. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

Authors: Du Le thi Huong; Zahir Amoura; Pierre Duhaut; Abdallah Sbai; Nathalie Costedoat; Bertrand Wechsler; Jean-Charles Piette
Journal: J Rheumatol Date: 2002-12 Impact factor: 4.666

3. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors: P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal: N Engl J Med Date: 2000-11-30 Impact factor: 91.245

4. Treatment with infliximab for a child with Behçet's disease.

Authors: Frank T Saulsbury; James A Mann
Journal: Arthritis Rheum Date: 2003-08-15

5. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

Authors: P Rutgeerts; G D'Haens; S Targan; E Vasiliauskas; S B Hanauer; D H Present; L Mayer; R A Van Hogezand; T Braakman; K L DeWoody; T F Schaible; S J Van Deventer
Journal: Gastroenterology Date: 1999-10 Impact factor: 22.682

6. Infliximab as a novel therapy for refractory Kawasaki disease.

Authors: Jennifer E Weiss; B Anne Eberhard; Devyani Chowdhury; Beth S Gottlieb
Journal: J Rheumatol Date: 2004-04 Impact factor: 4.666

7. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

Authors: Anthony Booth; Lorraine Harper; Tariq Hammad; Paul Bacon; Megan Griffith; Jeremy Levy; Caroline Savage; Charles Pusey; David Jayne
Journal: J Am Soc Nephrol Date: 2004-03 Impact factor: 10.121

8. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.

Authors: P Bartolucci; J Ramanoelina; P Cohen; A Mahr; P Godmer; C Le Hello; L Guillevin
Journal: Rheumatology (Oxford) Date: 2002-10 Impact factor: 7.580

9. Diagnostic criteria for polyarteritis nodosa in childhood.

Authors: S Ozen; N Besbas; U Saatci; A Bakkaloglu
Journal: J Pediatr Date: 1992-02 Impact factor: 4.406

10. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.

Authors: S A Siegel; D J Shealy; M T Nakada; J Le; D S Woulfe; L Probert; G Kollias; J Ghrayeb; J Vilcek; P E Daddona
Journal: Cytokine Date: 1995-01 Impact factor: 3.861

5 in total

Review 1. [Orphan diseases in rheumatology. Exemplified by polyarteritis nodosa].

Authors: A Rubbert-Roth
Journal: Z Rheumatol Date: 2012-02 Impact factor: 1.372

Review 2. Infliximab for the treatment of refractory polyarteritis nodosa.

Authors: Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Michael Rozenbaum; Lisa Kaly; Nizar Jiries; Nina Boulman; Abid Awisat; Haya Hussein; Irina Novofastovski; Amal Silawy; Doron Rimar
Journal: Clin Rheumatol Date: 2019-04-10 Impact factor: 2.980

Review 3. Systemic vasculitis in childhood.

Authors: Abraham Gedalia; Raquel Cuchacovich
Journal: Curr Rheumatol Rep Date: 2009-12 Impact factor: 4.592

Review 4. Medium-size-vessel vasculitis.

Authors: Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal: Pediatr Nephrol Date: 2009-11-28 Impact factor: 3.714

Review 5. Vasculitis in children.

Authors: Despina Eleftheriou; Paul A Brogan
Journal: Best Pract Res Clin Rheumatol Date: 2009-06 Impact factor: 4.098

5 in total